✦ LIBER ✦

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

✍ Scribed by C. Kollmannsberger; N. Schleucher; O. Rick; B. Metzner; J.T. Hartmann; P. Schöffski; J. Beyer; J. Casper; M. Sosada; H.-J. Schmoll; I. Böhlke; C. Meisner; L. Kanz; C. Bokemeyer

Book ID: 117659968
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 169 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(03)00003-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy with autologous hemato

High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy

✍ Bearman, S I; Vredenburgh, J J; Cagnoni, P J; Shpall, E J; Nieto, Y; Ross, M; Pe 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

247: High-Dose Chemotherapy with Autolog

247: High-Dose Chemotherapy with Autologous Stem-Cell Support Versus Standard-Dose Chemotherapy for High-Risk Breast Cancer: Meta-Analysis of Individual Patient Data from 15 Randomized Adjuvant Trials

✍ N.T. Ueno; D.A. Berry; M.M. Johnson; X. Lei; V.T. Lopez; J.A. Caputo; M. Bregni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The use of high-dose cyclophosphamide, c

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

✍ Yee Chung Cheng; Gabriela Rondón; Ying Yang; Terry L. Smith; James L. Gajewski; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB

A phase II study of two cycles of high-d

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

✍ Bashey, A; Corringham, S; Garrett, J; Lane, T A; Gilpin, E A; Corringham, R E T; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB